ULK1 activators

1. ULK1 activators inhibit tauopathies in cells.

   “Using in vitro tau seeding assays and a Caenorhabditis elegans tau model, we validate the efficacy of ULK1 activators in inhibiting tauopathy.”

   Cellsin vitro tau seeding assays

   Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer's disease pathology

   Nature aging·14 May 2026

2. ULK1 activators inhibit tauopathies in worms.

   “Using in vitro tau seeding assays and a Caenorhabditis elegans tau model, we validate the efficacy of ULK1 activators in inhibiting tauopathy.”

   Model organismstau model

   Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer's disease pathology

   Nature aging·14 May 2026

More on Tauopathies